https://medixway.com/adhd/adderall/

Adderall (immediate-release) is FDA-approved for children 3 years and older for ADHD treatment, but current clinical guidelines strongly recommend behavioral therapy as first-line treatment for children under 6 years, with medication only considered for those 4-5 years with moderate-to-severe dysfunction that hasn't responded to behavioral interventions. Prescribing stimulants to preschool children without first trying behavioral interventionsFailing to screen adolescents for substance use before prescribingNot monitoring for potential diversion in adolescentsInadequate dose titration leading to either insufficient effect or unnecessary side effectsThe evidence strongly suggests that while Adderall IR is technically approved for children as young as 3 years, clinicians should exercise significant caution when prescribing to children under 6 years, with behavioral interventions being the clear first-line approach for this younger age group